Pilot Study of Virtual Reality for Providing Exposure Therapy to Children
|ClinicalTrials.gov Identifier: NCT03208348|
Recruitment Status : Completed
First Posted : July 5, 2017
Last Update Posted : April 24, 2018
|Condition or disease||Intervention/treatment||Phase|
|Generalized Anxiety Disorder||Other: Pilot Virtual Reality||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||A single group will pilot test a virtual reality system that is designed to support mental health treatment.|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders|
|Actual Study Start Date :||September 1, 2017|
|Actual Primary Completion Date :||January 31, 2018|
|Actual Study Completion Date :||January 31, 2018|
Experimental: Pilot virtual reality
Children with anxiety will have a single visit to test the virtual reality system and measure its affects on their anxiety ratings.
Other: Pilot Virtual Reality
Exposure to a virtual reality vignette with anxiety rating to support exposure therapy
- Qualitative response to the system as assessed by observation while using the system and interview following use. [ Time Frame: through study completion, an average of one day study visit ]Twenty participants will provide qualitative data about their experience using the system.
- Anxiety as assessed by the Subjective Units of Distress Scale [ Time Frame: through study completion, an average of one day study visit ]Anxiety for each of the twenty participants will be assessed using SUDS prior to and after each time repeating the exposure. Participants will self-select how many times to repeat the exposure during the one day study visit.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03208348
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Sara Seifert, MPH||Minnesota HealthSolutions|